Ingersoll Rand Beats EPS, Holds Guidance as Segments Diverge
Ingersoll Rand posted a double‑digit rise in adjusted earnings per share and met its revenue and adjusted EBITDA targets for the quarter, but a modest dip in overall EBITDA margin and mixed segment trends kept the stock under pressure. Management reaffirmed full‑year 2026 guidance, emphasizing the IRX execution framework, a healthy order backlog and a continued M&A pipeline.
*** Ingersoll Rand (IR) delivered an earnings beat that was largely expected by the market, yet the reaction was muted – the shares slipped 3.3% to $81.27 on a day when the S&P 500 fell only 0.48%. The disconnect stems from a combination of modest margin compression, a nuanced segment split, and a guidance outlook that, while solid, offered no upside surprise.
Top‑line performance The company reported total revenue of $1.847 billion, up 8% year‑over‑year (7% on a currency‑neutral basis). Adjusted net income rose 7% to $305 million, translating to $0.77 per share, comfortably beating consensus estimates. Adjusted EBITDA climbed 2% to $469 million, yielding a 25.4% margin – a slight decline from the prior year’s 26.6% after a 210‑basis‑point slide in the Industrial Technologies & Services (IT&S) segment.
Segment divergence - Industrial Technologies & Services (IT&S): Orders rose 5% YoY, but organic growth was negative (‑3%). Revenue grew 7% (‑2% organic) while adjusted EBITDA fell 1% to $386 million, pushing the segment margin to 26.7%, down 210 bps. The decline reflects organic volume weakness offset by tariff‑related pricing adjustments. Book‑to‑bill remained healthy at 1.08×, and management expects Middle‑East order disruptions to be fully recovered during the year. - Precision & Science Technologies (P&ST): The brighter half of the business, with orders up 6% (1% organic) and revenue up 10% (4% organic). Adjusted EBITDA surged 15% to $122 million, expanding the margin to 30.3% – a 120‑bp improvement. The segment’s book‑to‑bill of 1.04× underscores sustained demand for high‑precision equipment.
The contrasting trajectories mean the company’s overall adjusted EBITDA margin slipped modestly, but the growth in P&ST provides a cushion against the softness in IT&S.
Cash generation and capital allocation Operating cash flow was $200 million, and free cash flow after capex stood at $163 million, reflecting a 95% conversion of free cash flow to adjusted net income – in line with management’s target. Liquidity remains robust at $3.9 billion, comprising $1.3 billion of cash and $2.6 billion of undrawn credit facilities. Net debt to adjusted EBITDA leverage ticked up to 1.7×, a modest rise driven by higher EBITDA rather than additional borrowing.
The company returned $89 million to shareholders via share repurchases and paid an $8 million quarterly dividend. M&A activity continued with a $52 million acquisition of Scinomix and the announced purchase of Fox s.r.l., a maker of hydropneumatic accumulators, slated to close on April 30.
Guidance outlook Management reaffirmed its full‑year 2026 targets, projecting revenue growth of 2.5%‑4.5% (including a +0.5% currency tailwind) and adjusted EPS of $3.45‑$3.57, roughly a 5% increase at the midpoint. Adjusted EBITDA is expected to run between $2.13 billion and $2.19 billion, with corporate costs around $170 million and net interest expense near $230 million. The guidance assumes no material impact from Section 232 tariffs or the ongoing Middle‑East conflict.
The guidance cadence is noteworthy: while the company kept its outlook unchanged, the absence of an upward revision signals that management views the current trajectory as realistic but not extraordinary. Analysts, as reflected in a recent Seeking Alpha scorecard, noted that 19 of 23 S&P 500 industrial peers beat EPS estimates this week, positioning Ingersoll Rand’s beat as broadly in line with sector momentum.
Strategic themes - IRX execution excellence: The company continues to lean on its IRX framework to drive cost discipline and operational efficiency, especially in the higher‑margin P&ST business. - M&A pipeline: The Fox acquisition expands the company’s footprint in fluid power, complementing the Scinomix deal and potentially bolstering future organic growth. - Geopolitical resilience: Management’s confidence that Middle‑East order disruptions will be recovered, coupled with a neutral stance on tariff impacts, suggests a focus on demand fundamentals rather than short‑term headwinds.
Market reaction Despite beating the EPS consensus, the stock’s decline reflects investors’ focus on margin pressure and the lack of a guidance lift. With the RSI at 42 and the price sitting near the lower third of its 52‑week range, the market appears to be pricing in a cautious outlook, awaiting evidence that P&ST momentum can offset IT&S softness.
Bottom line Ingersoll Rand delivered a solid earnings beat and reaffirmed its full‑year targets, but the mixed segment performance and modest margin compression kept the stock under pressure. The firm’s cash position, disciplined capital allocation and ongoing M&A activity provide a sturdy platform for 2026, yet investors will be watching the second half of the year closely to see whether the P&ST upside can lift overall profitability. ***
Financial Details
| Forward Guidance | |
| Revenue Guidance | Revenue growth of 2.5% to 4.5% for full‑year 2026 (currency impact ~+0.5%). |
| Eps Guidance | Adjusted EPS of $3.45 to $3.57 for full‑year 2026, representing approximately 5% growth at the midpoint. |
| Other Guidance | Adjusted EBITDA of $2,130 million to $2,190 million; corporate costs ~ $170 million; net interest expense ~ $230 million; adjusted tax rate ~ 23%; capex ~ 2% of sales; free cash flow to adjusted ne... |
| Commentary | Management stated that the company remains on track to meet its full‑year commitments, expects continued execution strength from IRX, and anticipates that the M&A pipeline will support revenue grow... |
| Segment Highlights | ['Industrial Technologies & Services (IT&S): Orders up 5% YoY (organic down 3%); revenues up 7% YoY (organic down 2%); adjusted EBITDA $386\u202fmillion, down 1% YoY; adjusted EBITDA margin 26.7%, down 210 bps; book‑to‑bill 1.08x; Middle‑East order impact expected to be recovered.', 'Precision & Science Technologies (P&ST): Orders up 6% YoY (organic up 1%); revenues up 10% YoY (organic up 4%); adjusted EBITDA $122\u202fmillion, up 15% YoY; adjusted EBITDA margin 30.3%, up 120 bps; book‑to‑bill 1.04x; strong operational execution driven by IRX.'] |
| Key Metrics | |
| Total Orders | $1,978 million (up 5% YoY) |
| Total Revenues | $1,847 million (up 8% YoY) |
| Net Income Attributable | $192 million ($0.49 per share) |
| Adjusted Net Income | $305 million ($0.77 per share, up 7%) |
| adjusted EBITDA | $469 million (up 2%) |
| adjusted EBITDA margin | 25.4% |
| Operating Cash Flow | $200 million |
| Free Cash Flow | $163 million |
| Liquidity | $3.9 billion (including $1.3 billion cash and $2.6 billion undrawn credit) |
| net debt to adjusted EBITDA leverage | 1.7x |
| Share Repurchases | $89 million |
| Dividend Paid | $8 million |
| M&A spend | $52 million (Scinomix acquisition) |
| New Acquisition Announced | Fox s.r.l. (hydropneumatic accumulators), closing April 30 2026 |
Key Takeaways
- Adjusted EPS beat expectations, rising 7% YoY to $0.77 per share.
- Revenue grew 8% YoY to $1.847 billion; adjusted EBITDA up 2% to $469 million, margin slipped to 25.4%.
- IT&S segment saw 5% order growth but a 1% EBITDA decline; P&ST delivered 10% revenue growth and a 15% EBITDA jump.
- Management reaffirmed 2026 guidance: 2.5%‑4.5% revenue growth, $3.45‑$3.57 adjusted EPS, $2.13‑$2.19 billion adjusted EBITDA.
- Liquidity stands at $3.9 billion with $89 million of share repurchases and an $8 million dividend; net debt/EBITDA at 1.7×.
- New acquisition of Fox s.r.l. adds hydropneumatic accumulator capability; M&A pipeline remains a growth lever.
- Shares fell 3.3% despite the beat, reflecting market concerns over margin compression and unchanged guidance.